share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  May 28 23:31
Summary by Futu AI
Vertex Pharmaceuticals Inc. officer Charles F. Wagner Jr. is set to sell 3,250 shares of common stock on 05/28/2024, as announced by the company. The shares, valued at approximately $1,478,067.50, were acquired through restricted stock vesting as part of compensation on two separate occasions, with 1,199 shares obtained on 02/10/2023 and an additional 2,051 shares on 02/13/2023. The planned sale follows the adoption of a trading plan on 02/26/2024. There have been no other reported sales of securities by Wagner in the past three months.
Vertex Pharmaceuticals Inc. officer Charles F. Wagner Jr. is set to sell 3,250 shares of common stock on 05/28/2024, as announced by the company. The shares, valued at approximately $1,478,067.50, were acquired through restricted stock vesting as part of compensation on two separate occasions, with 1,199 shares obtained on 02/10/2023 and an additional 2,051 shares on 02/13/2023. The planned sale follows the adoption of a trading plan on 02/26/2024. There have been no other reported sales of securities by Wagner in the past three months.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.